INS and Hypoglycemia: Basal insulin (NPH or analogue) or a sulfonylurea is the preferred next step in treatment intensification, although other agents may be more appropriate for an individual patient (e.g. a patient susceptible to or concerned about hypoglycaemia, with contraindications to or intolerance of metformin).